Outcomes and assessments Results for the primary and secondary outcomes were published 19
Interpretation of findings Weight loss improves cardiovascular risk factorsa recent trial showed that continuous use of semaglutide over four years reduced major cardiovascular disease events in individuals with existing cardiovascular disease.9 The benefits of weight loss on diabetes and other cardiovascular disease risk markers were, however, attenuated by weight regain.10 Based on projections of observed trends, we estimated that people who stop taking WMMs will regain weight at a rate of 0.4 kg/month, returning to baseline weight by 1.7 years and to no difference from control after 1.4 years
What are the benefits of medically supervised weight management
In addition to its antioxidant properties and support for cardiovascular function, resveratrol has been shown to support optimal immune function
Bhojraj specializes in cardiometabolic optimization, mitochondrial health, redox biology, and longevity-focused cardiovascular prevention
Youre probably here because youve heard the buzz about this weight loss injection thats got everyone talking
